Drugs and supplements that may slow aging of the epigenome

Drug Discovery Today: Therapeutic Strategies

Volumn 7, Issue 3-4, 2010, Pages 57-64

  Cooney, Craig A ^a  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPENE 1 THIOL; 5 AZA 2' DEOXYCYTIDINE; ACETYL COENZYME A; BUTYRIC ACID; DNA METHYLTRANSFERASE; DOXORUBICIN; ENTINOSTAT; ESTROGEN RECEPTOR ALPHA; GLUTAMATE DECARBOXYLASE; GLUTATHIONE TRANSFERASE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE METHYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; REELIN; SULFORAPHANE; THIOL DERIVATIVE; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; VORINOSTAT; ZEBULARINE;

AGE; AGING; ALZHEIMER DISEASE; ANAEROBIC GLYCOLYSIS; ARTICLE; ATHEROSCLEROSIS; BROCCOLI; CALORIC RESTRICTION; CANCER GROWTH; CANCER PREVENTION; CANCER SURVIVAL; CHOLESTEROL SYNTHESIS; CHROMATIN; COGNITIVE DEFECT; CUTANEOUS T CELL LYMPHOMA; DIABETES MELLITUS; DIET SUPPLEMENTATION; DNA METHYLATION; DRUG SYNTHESIS; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; EPIGENETICS; FATTY ACID SYNTHESIS; GARLIC; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; MEMORY; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRION; NEOPLASM; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROSTATE CANCER;

EID: 82955235548     PISSN: None     EISSN: 17406773     Source Type: Journal    
DOI: 10.1016/j.ddstr.2011.03.001     Document Type: Review

References (59)

1. Young, R.D. et al. (2010) Validated worldwide supercentenarians, living and recently deceased. Rejuvenation Res. 13, 127-132.
2. Eilertsen, K.J. et al. (2008) The epigenetics of adult (somatic) stem cells. Crit. Rev. Eukaryot. Gene Expr. 18, 189-206. (Pubitemid 351620285)
3. Cooney, C.A. (2008) Cancer and aging: the epigenetic connection. In Cancer Epigenetics (Tollefsbol ed), pp. 303-316, CRC Press.
4. Champagne, F.A. and Curley, J.P. (2009) Epigenetic mechanisms mediating the long-term effects of maternal care on development. Neurosci. Biobehav. Rev. 33, 593-600.
5. Wolff, G.L. et al. (1998) Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. Faseb J. 12, 949-957. (Pubitemid 28359576)
6. Cropley, J.E. et al. (2006) Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc. Natl. Acad. Sci. U.S.A. 103, 17308-17312. (Pubitemid 44788965)
7. Cooney, C.A. (2007) Epigenetics - DNA-based mirror of our environment? Dis. Markers 23, 121-137. (Pubitemid 46333647)
8. Cooney, C. (2009) Nutrients, epigenetics, and embryonic development. In Nutrients and Epigenetics (Choi, S. and Friso, S., eds), pp. 155-174, CRC Press.
9. Ooi, S.K. et al. (2009) Mammalian cytosine methylation at a glance. J. Cell Sci. 122 (Pt 16), 2787-2791.
10. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705. (Pubitemid 46273577)
11. Peleg, S. et al. (2010) Altered histone acetylation is associated with agedependent memory impairment in mice. Science 328, 753-756.
12. Kwabi-Addo, B. et al. (2007) Age-related DNA methylation changes in normal human prostate tissues. Clin. Cancer Res. 13, 3796-3802. (Pubitemid 47037584)
13. Maegawa, S. et al. (2010) Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 20, 332-340.
14. Irizarry, R.A. et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 41, 178-186.
15. Li, L.C. et al. (2005) Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J. Natl. Cancer Inst. 97, 103-115.
16. Elsheikh, S.E. et al. (2009) Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69, 3802-3809.
17. Safar, A.M. et al. (2005) Methylation profiling of archived non-small cell lung cancer: a promising prognostic system. Clin. Cancer Res. 11, 4400-4405. (Pubitemid 40825630)
18. Post, W.S. et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc. Res. 43, 985-991. (Pubitemid 29413198)
19. Miller, C.A. and Sweatt, J.D. (2007) Covalent modification of DNA regulates memory formation. Neuron 53, 857-869. (Pubitemid 46367557)
20. Kundakovic, M. et al. (2009) The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol. Pharmacol. 75, 342-354.
21. Russanova, V.R. et al. (2004) Semirandom sampling to detect differentiation-related and age-related epigenome remodeling. J. Gerontol. A: Biol. Sci. Med. Sci. 59, 1221-1233. (Pubitemid 40209408)
22. Kilgore, M. et al. (2010) Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease. Neuropsychopharmacology 35, 870-880.
23. Metivier, R. et al. (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature 452, 45-50. (Pubitemid 351355084)
24. Siliphaivanh, P. et al. (2007) Design of novel histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 17, 4619-4624. (Pubitemid 47058936)
25. Kattar, S.D. et al. (2009) Parallel medicinal chemistry approaches to selective HDAC1/HDAC2 inhibitor (SHI-1:2) optimization. Bioorg. Med. Chem. Lett. 19, 1168-1172.
26. Cho, Y.S. et al. (2010) Conformational refinement of hydroxamate-based histone deacetylase inhibitors and exploration of 3-piperidin-3-ylindole analogues of dacinostat (LAQ824). J. Med. Chem. 53, 2952-2963.
27. Nian, H. et al. (2009) Modulation of histone deacetylase activity by dietary isothiocyanates and allyl sulfides: studies with sulforaphane and garlic organosulfur compounds. Environ. Mol. Mutagen 50, 213-221.
28. Meeran, S.M. et al. (2010) Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 5, e11457.
29. Downing, C. et al. (2011) Subtle decreases in DNA methylation and gene expression at the mouse Igf2 locus following prenatal alcohol exposure: effects of a methyl-supplemented diet. Alcohol 45, 65-71.
30. Issa, J.P. and Kantarjian, H.M. (2009) Targeting DNA methylation. Clin. Cancer Res. 15, 3938-3946.
31. Tan, Y. et al. (2010) Broad selective efficacy of recombinant methioninase and polyethylene glycol-modified recombinant methioninase on cancer cells in vitro. Anticancer Res. 30, 1041-1046.
32. Pogribny, I.P. et al. (1995) Differential sensitivity to loss of cytosine methyl groups within the hepatic p53 gene of folate/methyl deficient rats. Carcinogenesis 16, 2863-2867.
33. Humphrey, L.L. et al. (2008) Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin. Proc. 83, 1203-1212.
34. Van Dam, F. and Van Gool, W.A. (2009) Hyperhomocysteinemia and Alzheimer's disease: a systematic review. Arch. Gerontol. Geriatr. 48, 425-430.
35. Wellen, K.E. et al. (2009) ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080.
36. Bonnet, S. et al. (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11, 37-51. (Pubitemid 46054520)
37. Wallace, D.C. et al. (2010) Mitochondrial energetics and therapeutics. Annu. Rev. Pathol. 5, 297-348.
38. Madiraju, P. et al. (2009) Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics 4, 399-403.
39. Prahl, S. et al. (2008) Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care. Biofactors 32, 245-255.
40. Lee, C.K. et al. (2002) Transcriptional profiles associated with aging and middle age-onset caloric restriction in mouse hearts. Proc. Natl. Acad. Sci. U.S.A. 99, 14988-14993.
41. Stanley, W.C. et al. (2005) Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85, 1093-1129. (Pubitemid 40894649)
42. Warburg, O. (1956) On respiratory impairment in cancer cells. Science 124, 269-270.
43. Semenza, G.L. (2008) Tumor metabolism: cancer cells give and take lactate. J. Clin. Invest. 118, 3835-3837.
44. Xie, C.H. et al. (2007) Mitochondrial regulation of cancer associated nuclear DNA methylation. Biochem. Biophys. Res. Commun. 364, 656-661.
45. Hadad, S.M. et al. (2008) Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit. Rev. Oncol. Hematol. 67, 1-7.
46. Algire, C. et al. (2010) Metformin blocks the stimulative effect of a highenergy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase. Endocr. Relat. Cancer 17, 351-360.
47. Gonzalez-Angulo, A.M. and Meric-Bernstam, F. (2010) Metformin: a therapeutic opportunity in breast cancer. Clin. Cancer Res. 16, 1695-1700.
48. Corbett, J.W. and Harwood, J.H., Jr (2007) Inhibitors of mammalian acetyl-CoA carboxylase. Recent Pat. Cardiovasc. Drug Discov. 2, 162-180. (Pubitemid 350200285)
49. Puig, T. et al. (2009) Novel inhibitors of fatty acid synthase with anticancer activity. Clin. Cancer Res. 15, 7608-7615.
50. Jin, Q. et al. (2010) Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells. Breast Cancer Res. 12, R96.
51. Hirsch, H.A. et al. (2010) A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell 17, 348-361.
52. Decensi, A. et al. (2010) Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev. Res. (PA) 3, 1451-1461.
53. Smith, D.L., Jr et al. (2010) Metformin supplementation and life span in Fischer-344 rats. J. Gerontol. A: Biol. Sci. Med. Sci. 65, 468-474.
54. Yu, Y. et al. (2010) Epigenetic drugs can stimulate metastasis through enhanced expression of the pro-metastatic Ezrin gene. PLoS One 5, e12710.
55. Miller, R.A. et al. (2005) Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 4, 119-125. (Pubitemid 41602745)
56. Fauce, S.R. et al. (2008) Telomerase-based pharmacologic enhancement of antiviral function of human CD8+ T lymphocytes. J. Immunol. 181, 7400-7406.
57. Ayyadevara, S. et al. (2008) Remarkable longevity and stress resistance of nematode PI3K-null mutants. Aging Cell 7, 13-22.
58. Marks, P.A. (2007) Discovery and development of SAHA as an anticancer agent. Oncogene 26, 1351-1356. (Pubitemid 46328465)
59. Zain, J. et al. (2010) Emerging role of epigenetic therapies in cutaneous Tcell lymphomas. Expert Rev. Hematol. 3, 187-203